Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma

Blood

Volumn 87, Issue 9, 1996, Pages 3860-3868

  Weisenburger, Dennis D ^a,b   Gordon, Bruce G ^a   Vose, Julie M ^a   Bast, Martin A ^a   Chan, Wing C ^a   Greiner, Timothy C ^a   Anderson, James R ^a   Sanger, Warren G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GENETICS; CHILD; CHROMOSOME 2P; CHROMOSOME 5Q; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 5; CLINICAL ARTICLE; FEMALE; HUMAN; KARYOTYPE; LARGE CELL LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 0029981836     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3860.bloodjournal8793860     Document Type: Article

References (58)

1. Stein H: Ki-1 anaplastic large cell lymphoma: Is it a discrete entity? Leuk Lymph 10:81, 1993
2. Kadin ME: Primary Ki-1-positive anaplastic large-cell lymphoma: A distinct clinicopathologic entity. Ann Oncol 5:25, 1994 (suppl 1)
3. +) in childhood. Med Pediatr Oncol 21:402, 1993
4. Murphy SB: Pediatric lymphomas: Recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhood. Ann Oncol 5:31, 1994 (suppt 1)
5. Sandlund JT, Pui CH, Roberts WM, Santana VM, Morris SW, Berard CW, Hutschison RE, Ribeiro RC, Mahmoud H, Crist WM, Heim M, Raimondi SC: Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 84:2467, 1994
6. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmerman M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner H, Riehm H: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Münster group studies. J Clin Oncol 12:899, 1994
7. Rubie H, Gladieff L, Robert A, Gaubert I, Huguet F, Rochait P, Pein F, Michel G, Hoerni B, Sommelet D, Delsol G: Childhood anaplastic large cell lymphoma Ki-1/CD30: Clinicopathologic features of 19 cases. Med Pediatr Oncol 22:155, 1994
8. Piris M, Brown DC, Gatter KC, Mason DY: CD30 expression in non-Hodgkin's lymphoma. Histopathoiogy 17:211, 1990
9. Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS: Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 9:539, 1991
10. Shulman LN, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, Mauch P, Nobles E, Mashal R, Canellos G, Tung N, Kadin M: Primary Ki-1 anapiastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 11:937, 1993
11. +): Results of a retrospective clinico-pathologic study of 69 cases. Br J Haematol 86:13, 1994
12. Romaguera JE, Manning JT, Tornos CS, Rodriguez J, Brooks TE, Pugh WC, Ordonez NG, Goodacre AM, Cabanillas F: Long term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma. Ann Oncol 5:317, 1994
13. Hutchison RE, Berard CW, Shuster JJ, Link MP, Pick TE, Murphy SB: B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: A Pediatric Oncology Group study. J Clin Oncol 13:2023, 1995
14. Stein H, Mason DY, Gerdes J, O'Conner N, Wainscoat J, Pallesen G, Gatter G, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
15. Suchi T, Lennert K, Tu L-Y, Kikuchi M, Sato E, Stansfeld AG, Feller AC: Histopathoiogy and immunohistochemistry of peripheral T cell lymphomas: A proposal for their classification. J Clin Pathol 40:995, 1987
16. Pileri SA, Piccaluga A, Poggi S, Sabattini E, Piccaluga PP, DeVivo A, Falini B, Stein H: Anaplastic large cell lymphoma: Update of findings. Leuk Lymph 18:17, 1995
17. Schwarting R, Gerdes J, Dürkop H, Falini B, Pileri S, Stein H: Ber-H2: A new anti-Ki-1 (CD30) monoclonal antibody directed at a formal-resistant epitope. Blood 74:1678, 1989
18. Penny RJ, Blaustein JC, Longtine JA, Pinkus GS: Ki-1-positive large cell lymphomas, a heterogeneous group of neoplasms. Cancer 68:362, 1991
19. Miettinen M: CD30 distribution: Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Arch Pathol Lab Med 116:1197, 1992
20. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Newmann C, Rosso R, Paulli M, Meijer CJLM, Willemze R: Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. Cancer 71:2097, 1993
21. Noorduyn LA, de Bruin PC, van Heerde P, van de Sandt MM, Ossenkoppele GJ, Meijer CJLM: Relation of CD30 expression to survival and morphology in large cell B cell lymphomas. J Clin Pathol 47:33, 1994
22. Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol 71:31, 1989
23. Knuutila S, Lakkala T, Teerenhovi L, Peltomäki P, Kovanen R, Franssila K: t(2;5)(p23;q35) - A specific chromosome abnormality in large cell anaplastic (Ki-1) lymphoma. Leuk Lymph 3:59, 1990
24. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, LeBeau MM, Stephens JK, Vardiman JW: Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and a unique chromosomal abnormality, t(2;5) (p23;q35). Am J Surg Pathol 14:305, 1990
25. Ebrahim SAD, Ladanyi M, Desai SB, Offit K, Jhanwar SC, Filippa DA, Lieberman PH, Chaganti RSK: Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage. including 12 Ki-1 positive lymphomas. Genes Chromosome Cancer 2:27, 1990
26. Kaneko Y, Frizzera G, Edamura S, Maseki N, Sakurai M, Komada Y, Sukurai M, Tanaka H, Sasaki M, Suchi T, Kituta A, Wakasa H, Hojo H, Mizutant S: A novel translocation, t(2:5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806, 1989
27. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Knstoffersson U, Magaud JP, Nezelof C, Tilly H, Vannier JP, Hemet J, Warnke R: CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
28. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphoma. Cancer Res 54:2873, 1994
29. Lopategui JR, Sun LH, Chan JKC, Gaffey MJ, Frierson HF, Glackin C, Weiss LM: Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. Am J Pathol 146:325, 1995
30. Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenburger DD, Kossakowska AE, Thorner P, Lorenzana A, Ladanyi M, Morris SW: Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:416, 1995
31. Elmberger PG, Lozano MD, Weisenburger DD, Sanger W, Chan WC: Transcripts of the NPM-ALK fusion gene in anaplastic large cell lymphoma, Hodgkin's disease and reactive lymphoid lesions. Blood 86:3517, 1995
32. - anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell type, and in Hodgkin's disease. Blood 86:2321, 1995
33. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 49:2112, 1982
34. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. Histochem Cytochem 29:577, 1981
35. Baddoura FK, Chan WC, Masih AS, Mitchell D, Sun NCJ, Weisenburger DD: T-cell-rich B-cell lymphoma: A clinicopathologic study of eight cases. Am J Clin Pathol 103:65, 1995
36. Delabie J, Tierens A, Wu G, Weisenburger DD, Chan WC: Lymphocyte predominance Hodgkin's disease: Lineage and clonality determination using a single-cell assay. Blood 84:3291, 1995
37. Greiner TC, Raffeid M, Lutz C, Dick F, Jaffe ES: Analysis of T cell receptor-γ gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Am J Pathol 146:46, 1995
38. Nashelsky MB, Hess MM, Weisenburger DD, Pierson JC, Bast MA, Armitage JO, Sanger WG: Cytogenetic abnormalities in B-immunoblastic lymphoma. Leuk Lymph 14:415, 1994
39. Cancer Cytogenetics: Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1991
40. Kaplan GL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
41. Weisenburger DD, Linder J, Armitage JO: Peripheral T-cell lymphoma: A clinicopathologic study of 42 cases. Hematol Oncol 5:175, 1987
42. Chakravarti V, Kamani NR, Bayever E, Lange B, Herzog P, Sanders JE, August CS: Bone marrow transplantation for childhood Ki-1 lymphoma. J Clin Oncol 8:657, 1990
43. Gordon BG, Warkentin PI, Weisenburger DD, Vose JM, Sanger WG, Strandjord SE, Anderson JR, Verdirame JD, Bierman PJ, Armitage JO, Coccia PF: Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. Blood 80:2938, 1992
44. Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sander S, Sykora KW, Ludwig WD, Gadner H, Riehm H: Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes - A report of the Berlin-Frankfurt-Münster Group. J Clin Oncol 13:359, 1995
45. Chan JKC, Ng CS, Hui PK, Leung TW, Lo ESF, Lau WH, McGuire LJ: Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathology 15:11, 1989
46. Chott A, Kasever K, Augustin I, Vesely M, Heinz R, Oehlinger W, Hanak H, Radaszkiewicz T: Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 14:349, 1990
47. + with a high content of reactive histiocytes). Histopathology 16:383, 1990
48. + T-cell lymphoma. Am J Surg Pathol 17:859, 1993
49. Armitage JO, Greer JP, Levine AM, Weisenburger DD, Formenti SC, Bast M, Conley S, Pierson J, Linder J, Cousar J, Nathwani BN: Peripheral T-cell lymphoma. Cancer 63:158, 1989
50. Leake J, Kellie SJ, Pritchard J, Chessells JM, Risdon RA: Peripheral T-cell lymphoma in childhood. A clinicopathologic study of six cases. Histopathology 14:255, 1989
51. Gordon BG, Weisenburger DD, Warkentin PI, Anderson J, Sanger WG, Bast M, Gnarra D, Vose JM, Bierman PJ, Armitage JO, Coccia PF: Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients. Cancer 71:257, 1993
52. Saha V, Eden OB, Hann I, Attard-Montalto S, Coterill S, Carter R: Primary extrathoracic T-cell non-Hodgkin's lymphoma of childhood. Leukemia 9:40, 1995
53. Nakamura S, Takagi N, Kojima M, Motoori T, Kitoh K, Osada H, Suzuki H, Ogura M, Kurita S, Oyama A, Ueda R, Takahashi T, Suchi T: Clinicopathologic study of large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among the Japanese. Cancer 68:118, 1991
54. de Bruin PC, Noorduyn AL, van der Valk P, van Heerde P, van Diest PJ, van de Sandt MM, Ossenkoppele GJ, Meijer CJLM: Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis. Cancer 71:2604, 1993
55. Lakkala-Paranko T, Franssila K, Lappalainen K, Leskinen R, Knuutila S, de la Chapelle A, Bloomfield CD: Chromosome abnormalities in peripheral T-cell lymphoma. Br J Haematol 66:451, 1987
56. Berger R, Baranger L, Berheimm A, Valensi F, Flandrin G: Cytogenetics of T-cell malignant lymphoma. Report of 17 cases and review of the chromosomal breakpoints. Cancer Genet Cytogenet 36:123, 1988
57. Schouten HC, Sanger WG, Weisenburger DD, Armitage JO: Chromosomal abnormalities in patients with noncutaneous T-cell non-Hodgkin's lymphoma. Eur J Cancer 26:618, 1990
58. Schlegelberger B, Himmler A, Gödde E, Grote W, Feller AC, Lennert K: Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 83:505, 1994